Wird geladen...
Biphasic human insulin 30 thrice daily, is it reasonable?
OBJECTIVE: To evaluate the efficacy and safety of thrice daily Biphasic Human Insulin 30 (BHI 30) versus the traditional twice-daily regimen in type 2 diabetes mellitus (T2DM) patients. It’s a cross over single clinical study. Twenty-two diabetic patients who were already using BHI 30 in twice or th...
Gespeichert in:
| Veröffentlicht in: | BMC Res Notes |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7247174/ https://ncbi.nlm.nih.gov/pubmed/32448382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-020-05090-6 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|